Press releases
- AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
- AngioDynamics Receives 510(k) Clearance for AlphaVac F18⁸⁵ System in Treatment of PE
- AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
- AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
- AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
- AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
More ▼
Key statistics
As of last trade, AngioDynamics Inc (UG2:FRA) traded at 5.30, 11.34% above the 52 week low of 4.76 set on Mar 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.30 |
---|---|
High | 5.30 |
Low | 5.30 |
Bid | 5.40 |
Offer | 5.55 |
Previous close | 5.30 |
Average volume | 0.00 |
---|---|
Shares outstanding | 40.05m |
Free float | 38.05m |
P/E (TTM) | -- |
Market cap | 231.52m USD |
EPS (TTM) | -4.78 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 07:05 BST.
More ▼